BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16886952)

  • 1. Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients.
    Leaños-Miranda A; Cárdenas-Mondragón G; Rivera-Leaños R; Ulloa-Aguirre A; Goffin V
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):146-53. PubMed ID: 16886952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays.
    Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Goffin V; Leaños-Miranda A
    J Rheumatol; 2007 Jul; 34(7):1514-21. PubMed ID: 17516622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia.
    Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):72-6. PubMed ID: 17681026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay.
    Glezer A; Soares CR; Vieira JG; Giannella-Neto D; Ribela MT; Goffin V; Bronstein MD
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1048-55. PubMed ID: 16384849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of prolactin in lactating rats and their pups: biological and immunological activities in pituitary gland, serum and milk.
    Kacsóh B; Tóth BE; Avery LM; Yamamuro Y; Grosvenor CE
    Endocr Regul; 1991 Jun; 25(1-2):98-110. PubMed ID: 1958841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
    Smith CR; Butler J; Hashim I; Norman MR
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroprolactinaemia associated with prolactin adenoma.
    Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
    Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.
    Leaños-Miranda A; Cárdenas-Mondragón G
    Rheumatology (Oxford); 2006 Jan; 45(1):97-101. PubMed ID: 16249247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroprolactin: what is it and what is its importance?
    Sadideen H; Swaminathan R
    Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity.
    Bernichtein S; Jeay S; Vaudry R; Kelly PA; Goffin V
    Endocrine; 2003; 20(1-2):177-90. PubMed ID: 12668884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
    Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
    Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin size heterogeneity in human follicular fluid: a preliminary study.
    Subramanian MG; Sacco AG; Moghissi KS; Lawson DM; Gala RR
    Int J Fertil; 1991; 36(6):367-71. PubMed ID: 1684962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.